• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL2100184 甲磺酸伏美替尼片 furmonertinib mesilate Tablet Chemical Drugs(2.4) New Drug Application 2021-03-16 上海艾力斯医药科技股份有限公司 Shanghai Allist Pharmaceuticals Co Ltd In Review 2021-03-15 view
CXHL2000557 甲磺酸伏美替尼片 furmonertinib mesilate Tablet Chemical Drugs(1) New Drug Application 2020-11-05 上海艾力斯医药科技股份有限公司 Shanghai Allist Pharmaceuticals Co Ltd In Review 2020-11-04 view